News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Chindex International, Inc. (CHDX) Agrees To Higher $24/Share Bid From Insiders


4/21/2014 12:17:42 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

April 21, 2014 -- Chindex, which operates private hospitals and clinics in China, accepted a buy-out offer of $24 per share from company insiders, which values the company at $434 million. The latest offer tops a $23 per share bid by an unnamed suitor, which refused the board’s invitation to raise its offer. The insiders consist of Fosun Pharma, which already owns 17.5% of Chindex, the US private equity group TPG and Roberta Lipson, the company’s founder and CEO. More details....

Stock Symbols: (NSDQ: CHDX) (SHA: 000196; HK: 2196)

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES